Updated March 30 at 6:25pm
Biotechnology
70 results total, viewing 61 - 70
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
Undergraduate students of Rhode Island’s colleges and universities will present their summer research at the ninth annual Rhode Island Summer Undergraduate Research Fellows conference on July 29. more
A recent report from CBRE, a real estate services firm, which analyzed U.S. tech employment over the past five years, listed the top 50 technology markets in the United States, but Providence was not one of them. more
The Slater Technology Fund on Monday announced it is committing another $250,000 to the biomedical company ProThera Biologics, bringing Slater’s total investment in the company to $950,000. more
Gov. Gina M. Raimondo opened the second round of the state’s Innovation Voucher Program for applications on Tuesday at an event hosted by Brown University’s Warren Alpert Medical School. more
Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during spinal surgeries and will take an equity stake of up to 15 percent in the company. Mazor’s stock surged. more
Dr. Barrett Bready is founder and CEO of Nabsys, a genomics firm. An adjunct professor at Brown University where he teaches biotechnology management, Bready also serves as a commissioner on the I-195 Redevelopment District Commission. Bready talked with Providence Business News about Nabsys’ evolution and goals for the future. more
MedMates, the life sciences technology-networking group, is hosting a Life Sciences Expo on April 26 to showcase innovation happening in the Ocean State, and beyond its borders. more
(Updated, Dec. 19, 4:40 p.m.) EpiVax Inc. is part of a team that has been awarded a $1.87 million grant from Department of Defense’s Defense Threat Reduction Agency to develop an effective vaccine against a bacterium that leads to melioidosis, a tropical disease that is resistant to many antibiotics. more
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7